Adverum Biotechnologies (ADVM) Q4 2025 Earnings

12NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-2.34
-1.99
-1.65
-1.3

Details

Expected EPS
-1.7547
Actual EPS
-1.55
Surprise EPS
0.2
Surprise Percent
+11.67%

Description

Adverum Biotechnologies (ADVM) has reported earnings of -1.55 per share for Q4 2025.

0 Comments

Share your thoughts